Population Pharmacokinetics of Fosdagrocorat (PF‐04171327), a Dissociated Glucocorticoid Receptor Agonist, in Patients With Rheumatoid Arthritis

類似資料

• Fosdagrocorat (PF-04171327) versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phase IIb study
  著者:: Buttgereit, Frank, 等
  出版事項: (2019)
• Improved disease activity with fosdagrocorat (PF‐04171327), a partial agonist of the glucocorticoid receptor, in patients with rheumatoid arthritis: a Phase 2 randomized study
  著者:: Stock, Thomas, 等
  出版事項: (2017)
• Maraviroc modelling strategy: use of early phase 1 data to support a semi-mechanistic population pharmacokinetic model
  著者:: Weatherley, Barry, 等
  出版事項: (2009)
• Dissociated Agonist of Glucocorticoid Receptor or Prednisone for Active Rheumatoid Arthritis: Effects on P1NP and Osteocalcin Pharmacodynamics
  著者:: Shoji, S, 等
  出版事項: (2017)
• In Vitro and In Vivo Investigation of Potential for Complex CYP3A Interaction for PF‐00251802 (Dagrocorat), a Novel Dissociated Agonist of the Glucocorticoid Receptor
  著者:: Ripp, Sharon L., 等
  出版事項: (2017)